1. Introduction {#sec1}
===============

With the help of radiographic and endoscopic system and special surgical tools, the minimally invasive posterior lumbar surgery was developed and worldwide popularly in last decades \[[@B1], [@B2]\]. It was reported the minimally invasive spinal surgery techniques had advantages of shorter skin wound incision, less muscle trauma, less blood loss, and hospital stay \[[@B3]--[@B5]\].

Currently, the minimally invasive (MI) lumbar spinal fusion techniques including MI posterior lumbar interbody fusion \[[@B6]\], MI transforaminal lumbar interbody fusion \[[@B7], [@B8]\], MI posterolateral lumbar fusion, MI lateral lumbar fusion \[[@B9]\], MI oblique lumbar interbody fusion, and MI anterior lumbar interbody fusion. The posterior approach permits the decompression and discectomy directly and does not have complications of vessel, hypogastric sympathetic plexus, and ureter injury, which may be caused by anterior approach \[[@B10]--[@B12]\], and is most widely used nowadays \[[@B13]\].

And the previous systematic review and meta-analysis in literatures showed that MI transforaminal lumbar interbody fusion appears similar safety and efficacy to open transforaminal lumbar interbody fusion and associated with lower blood loss and infection rates for general degenerative lumbar disease patient \[[@B14], [@B15]\].

However, spondylolisthesis is one of the most lumbar spinal disorders and may be caused by isthmic or degeneration. The symptoms of spondylolisthesis include low back pain and leg pain, decreasing walk ability, and neurogenic claudication. Surgical interventions were recommended when the symptoms could not be relieved by conservative treatment \[[@B16]--[@B18]\]. The difference of spondylolisthesis to other degenerative lumbar diseases (such as lumbar stenosis without spondylolisthesis and lumbar disc herniated) is that in spondylolisthesis patients the vertebrae will be slipped anteriorly. The traditional open spinal fusion, which performed laminectomy to completely decompression the spinal canal and nerve root, was recognized as one of the "gold standard" methods in treatment of spondylolisthesis and had credible pain relief and function improvement \[[@B19], [@B20]\]. MI technique may be hard to achieve completely decompression because of the limited vision; therefore, the clinical efficacy and safety of minimally invasive posterior spinal fusion in treatment of lumbar spondylolisthesis are still controversial. In this study, we aim to provide the best evidence from current prospective comparative studies for surgeons and researchers.

2. Methods {#sec2}
==========

This systematic review and meta-analysis was done according to the preferred reporting items for systematic review and meta-analyses (PRISMA) guidelines (Checklist S1 in Supplementary Material available online at <https://doi.org/10.1155/2017/8423638>) \[[@B21]\]. No primary personal data will be collected; therefore no additional ethical approval needs to be obtained.

2.1. Search Strategy {#sec2.1}
--------------------

Two authors (Chun-Hui Chen and Zhi-Hao Shen) independently searched the electronic literature database of Pubmed, Embase, and Cochrane library, without language limitation at April 2016. The key words were used as follows: posterior lumbar interbody fusion, transforaminal lumbar interbody fusion, posterolateral lumbar fusion, posterior lumbar fusion, posterior lumbar arthrodesis, minimally invasive lumbar fusion, minimally invasive fusion, spondylolisthesis, isthmic spondylolisthesis, and degenerative spondylolisthesis. One of search strategy developed with comprehensive use of keywords performed in Pubmed was showed in Table S1. Related articles and reference lists were searched to avoid original miss.

2.2. Eligibility Criteria {#sec2.2}
-------------------------

The study was included in this meta-analysis if it was (1) prospective randomized controlled trial (RCT) or nonrandomized prospective comparative study; (2) it compared the clinical outcomes of minimally invasive posterior approach lumbar fusion versus traditional open posterior approach lumbar fusion; (3) the participants were spondylolisthesis (including isthmic and degenerative spondylolisthesis); (4) it was with a follow-up term of at least 12 months.

Exclusion criteria were as follows: (1) respective studies, case series, case report, and review articles; (2) follow-up of less than 12 months; (3) duplicated publications from the same hospital or research center.

2.3. Selection of Literature {#sec2.3}
----------------------------

We used the PRISMA flow diagram to select the included studies ([Figure 1](#fig1){ref-type="fig"}); the results of literature search were imported into the software Endnote X4. Two authors (Zhen-Hua Feng and Wan-Qing Weng) independently assessed the potentially eligible studies. Firstly, the titles and abstracts were screened to exclude the duplicated and apparently irrelevant ones or those that do not meet our inclusion criteria. After then, the remaining potential studies were full-text downloaded and reviewed. Any disagreement between two above authors was sent and discussed with the third independent author (Ai-Min Wu).

2.4. Data Extraction {#sec2.4}
--------------------

Two reviewers (Chun-Hui Chen and Shu-Min Li) independently extracted data, and the third reviewer (Wen-Fei Ni) checked the consistency between them. A standard form was used; the extracted items included the following: (1) the general study information, for example, the authors, publishing date, country, name of investigate site, study design, sample size, age, gender, index levels, follow-up term; (2) perioperative parameters, including operative time, estimated blood loss, X-ray exposure, and length of hospital stay; (3) clinical outcomes, including visual analog scale (VAS) of both lower back pain and leg pain, Oswestry disability index (ODI), SF-36 PCS (physical component scores), and SF-36 MCS (mental component scores); (4) complications, nonfusion rate, and secondary surgery; the complications included dural tear, wound infection, screw or rod fracture, graft dislodgement, epidural hematoma, and adjacent disc disease. For continuous outcomes, we extracted the mean and SD (standard deviation) and participant number will be extracted. For dichotomous outcomes, we extracted the total numbers and the numbers of events of both groups. The data in other forms was recalculated when possible to enable pooled analysis.

2.5. Quality Assessment of Included Studies {#sec2.5}
-------------------------------------------

The methodological index for nonrandomized studies (MINORS) was used to assess the quality of the included studies \[[@B22], [@B23]\]. Twelve items were scored as "0" (not reported), "1" (reported but inadequate), or "2" (reported and adequate). Two reviewers (Ai-Min Wu and Yong-Long Chi) independently assessed the quality of the included studies.

2.6. Statistical Analysis {#sec2.6}
-------------------------

The data was collected and input into the STATA software (version 12.0; StataCorp, College Station, TX) for meta-analysis. Random-effects model was used to combine the data from individual studies. Relative risk (RR) was calculated for dichotomous outcomes such as complications, nonfusion, and secondary surgery. Standard mean difference (SMD) was calculated for continuous outcomes such as operative time, estimated blood loss, length of hospital stay, and clinical parameters. Heterogeneity was assessed using the *x*^2^ and *I*^2^. We defined the acceptable heterogeneity by *p* value of *x*^2^ test \> 0.10 and *I*^2^ \< 50%. For heterogeneity data, sensitivity analysis was involved to remove one study and evaluate whether the other results would be markedly affected.

3. Results {#sec3}
==========

3.1. Included Studies {#sec3.1}
---------------------

A total 1926 potential records were identified through Medline (*n* = 1228), Embase (*n* = 697), and Cochrane library (*n* = 1). The list of articles were input into software endnote X4, and then 243 duplicate articles were excluded, after titles and abstracts screened, leaving 21 full-text articles to be assessed for eligibility, and 16 were excluded for reasons of "the papers were review or retrospective studies or from same investigation site" and some other reasons (details were showed in [Figure 1](#fig1){ref-type="fig"}). Finally, five nonrandom prospective comparative studies \[[@B24]--[@B28]\] were included in this meta-analysis. The procedure of literatures selection was showed in [Figure 1](#fig1){ref-type="fig"} (PRISMA flow diagram).

3.2. Characteristics and Qualifications of Included Studies {#sec3.2}
-----------------------------------------------------------

The characteristics of all five included studies were summarized and shown in [Table 1](#tab1){ref-type="table"}. All the five included studies \[[@B24]--[@B28]\] were prospective comparative studies without random. They were from five different countries (Australia, China, Germany, Japan, and USA) and all of them were published after 2010. Total of 184 participants in MI group and 182 in OP group were included in this meta-analysis. The methodological quality assessment of the five included studies was summarized in [Table 2](#tab2){ref-type="table"}. The scores ranged from 18 to 20 with a median value of 19. The summary of outcomes of included studies was shown in [Table 3](#tab3){ref-type="table"}.

3.3. Perioperative Parameters {#sec3.3}
-----------------------------

All five studies \[[@B24]--[@B28]\] reported the operative time data of both groups; the meta-analysis showed that the MI group had a significantly longer operative time than OP group, with SMD = 0.36 (95% CI: 0.08, 0.64). Four studies \[[@B25]--[@B28]\] reported the data of estimated blood loss; the meta-analysis showed that the MI group had a significantly less blood loss than the OP group, with SMD = −1.42 (95% CI: −2.64, −0.20). Three studies \[[@B24], [@B25], [@B27]\] reported the length of hospital stay; the meta-analysis showed that the MI group had a significantly shorter hospital stay than the OP group, with SMD = −1.04 (95% CI: −1.48, −0.59) ([Figure 2](#fig2){ref-type="fig"}). Heterogeneity was observed in data of estimated blood loss (*I*^2^ = 95.4%, *p* = 0.000) and length of hospital stay (*I*^2^ = 58.9%, *p* = 0.088); sensitivity analysis found that there was no significant change when any study was omitted (Figures S1 and S2).

3.4. Clinical Outcomes {#sec3.4}
----------------------

Three studies \[[@B24], [@B25], [@B28]\] reported the data of back pain and two studies \[[@B24], [@B28]\] reported leg pain; the meta-analysis showed there was no significant difference between both MI and OP groups, SMD of back pain = −0.11 (95% CI: −0.39, 0.17) and SMD of leg pain = 0.03 (95% CI: −0.29, 0.35). Three studies \[[@B25], [@B27], [@B28]\] reported the data of ODI, and the meta-analysis showed that there was no significant difference between both MI and OP groups, with SMD of ODI = −0.91 (95% CI: −1.91, 0.09). Two studies \[[@B24], [@B28]\] reported SF-36 PCS and MCS, the meta-analysis showed that there was no significant difference between both MI and OP groups, SMD of SF-36 PCS = 0.24 (95% CI: −0.08, 0.56) and SMD of SF-36 MCS = 0.21 (95% CI: −0.12, 0.53) ([Figure 3](#fig3){ref-type="fig"}). Heterogeneity was observed in data of ODI, with *I*^2^ = 88.4%, *p* = 0.000; sensitivity analysis found that there was no significant change when any study was omitted (Figure S3).

3.5. Adverse Events {#sec3.5}
-------------------

Four studies \[[@B24]--[@B26], [@B28]\] reported the data of complications; the meta-analysis showed that there was no significant difference between both MI and OP groups, with RR = 0.96 (95% CI: 0.50, 1.83). Four studies \[[@B24]--[@B27]\] reported the data of nonfusion rate; the meta-analysis showed that there was no significant difference between both MI and OP groups, with RR = 1.29 (95% CI: 0.32, 5.17). And three studies \[[@B25], [@B26], [@B28]\] reported the data of secondary surgery; the meta-analysis showed that there was no significant difference between both MI and OP groups, with RR = 1.01 (95% CI: 0.33, 3.11) ([Figure 4](#fig4){ref-type="fig"}). No obvious heterogeneity was observed in data of complications, nonfusion, and secondary surgery.

4. Discussion {#sec4}
=============

The technique of posterior/posterolateral lumbar fusion had more than 100 years\' history \[[@B29]\], there are many different kinds of lumbar fusion now, and they are widely used in treatment of lumbar disc herniation, lumbar instability, and spondylolisthesis \[[@B13], [@B30]--[@B32]\]. To reduce the operative trauma \[[@B33], [@B34]\], Foley et al. reported using the miniopen tubule microsurgical approach with percutaneous pedicle screw fixation to achieve lumbar arthrodesis \[[@B1], [@B35]\]. The minimally invasive technique was modified and widespread in last decades.

Khan et al. \[[@B15]\] performed a meta-analysis of MI-TLIF versus open TLIF and found that the MI-TLIF can significantly reduce the blood loss, length of hospital stay, and complications; however, the fusion rate and operative time was similar. Another meta-analysis \[[@B14]\] found that the MI-TLIF not only reduced the blood loss more than open TLIF but also had significantly lower VAS of back pain and ODI scores.

In our this meta-analysis, only the spondylolisthesis patients were included, and we found that the MI technique can significantly reduce the estimated blood loss and length of hospital stay; however, it took more operative time. The decompression process of lumbar spondylolisthesis may need more time because of the limited space and vision, and the minimally invasive technique also needs a longer learning curve for surgeons \[[@B36], [@B37]\]. Another inconsistency to Phan et al.\' meta-analysis that we did not find significant difference in VAS of back pain and ODI scores between MI and OP groups. The patients with spondylolisthesis had the similar results in back and leg pain, ODI, and SF-36 scores, as well as complications, fusion rate, and secondary surgery between MI and OP groups.

Currently, MI lumbar fusion is mainly used in treatment of lower grade spondylolisthesis \[[@B25], [@B38]\]. Whether the MI lumbar fusion can be used in treatment of high-grade spondylolisthesis is still a controversial subject. Quraishi and Rampersaud reported that they use the minimally invasive bilateral transforaminal lumbar interbody fusion to treat high-grade isthmic spondylolisthesis \[[@B39]\], with estimated blood loss less than 100 ml, and about 150 minutes\' operating time. The slip percentage improved from 68% preoperatively to 28% postoperatively. Because the estimated blood loss is more than 1000 ml when high-grade spondylolisthesis patients underwent traditional open TLIF \[[@B40]\], they suggested the MI technique may have more advantage in blood loss in high-grade spondylolisthesis. The evidence that MI fusion is better for high-grade spondylolisthesis still needs further research.

*Strength and Limitation of This Study*. This study had many strengths; all of the included studies in this meta-analysis were prospective studies, which therefore overcomes the shortcomings of recall or selection bias in retrospective studies \[[@B41]\]. The methodological index for nonrandomized studies (MINORS) was used to assess the quality of the included studies, which had minimized scores of 18, the score range of 18 to 20.

However, there were still some limitations of present study, none of them was randomized control trials, the sample size was not very large, and the duration of follow-up was less than 5 years. Therefore, we suggested further long-term, larger sample size, and randomized control trials to be conducted.

5. Conclusions {#sec5}
==============

In summary, our present meta-analysis base prospective comparative studies suggested that MI posterior fusion for spondylolisthesis had less EBL and hospital stay than OP fusion; however it took more operative time. Both MI and OP fusion had similar results in pain and functional outcomes, complication, fusion rate, and secondary surgery.
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###### 

The characteristics of the included studies.

  ------------------------------------------------------------------------------------------------------------------------------------
  Authors                   Ghahreman et al.   Wang et al.       Archavlis and Carvi y Nievas   Kotani et al.       Parker et al.
  ------------------------- ------------------ ----------------- ------------------------------ ------------------- ------------------
  Year                      2010               2010              2013                           2012                2014

  Study design              PCT                PCT               PCT                            PCT                 PCT

  Country                   Australia          China             Germany                        Japan               USA

  Age (years)               MI: 53 (40--61)\   MI: 47.9 ± 8.5\   MI: 67 ± 8\                    MI: 63 ± 9\         MI: 53.5 ± 12.5\
                            OP: 60 (48--63)    OP: 53.2 ± 10.6   OP: 68 ± 7                     OP: 66 ± 9          OP: 52.6 ± 11.6

  Number of participants    MI: 25\            MI: 42\           MI: 24\                        MI: 43\             MI: 50\
                            OP: 27             OP: 43            OP: 25                         OP: 37              OP: 50

  Gender                                                                                                             

   Male                     MI: 12; OP: 13     MI: 13; OP: 16    MI: 14; OP: 10                 MI: 14; OP: 12      MI: 16; OP: 18

   Female                   MI: 13; OP: 14     MI: 29; OP: 27    MI: 17; OP: 8                  MI: 29; OP: 25      MI: 34; OP: 32

  Index levels                                                                                                       

   L3-4                     MI: 0; OP: 2       MI: 3; OP: 3      MI: 2; OP: 1                   4                   MI: 4; OP: 3

   L4-5                     MI: 11; OP: 10     MI: 21; OP: 23    MI: 16; OP: 17                 76                  MI: 32; OP: 30

   L5-S1                    MI: 11; OP: 15     MI: 18; OP: 17    MI: 6; OP: 7                   ---                 MI: 14; OP: 17

   L4-S1                    MI: 3; OP: 0       ---               ---                            ---                 ---

  Follow-up term (months)   12                 26 (13--35)       24                             MI: 32 (24--49);\   24
                                                                                                OP: 40 (24--60)     
  ------------------------------------------------------------------------------------------------------------------------------------

MI: minimally invasive TLIF group; OP: open TLIF group; PCT: prospective comparative trials.

###### 

Quality assessment of five included studies.

  Methodological item for nonrandomised studies                Ghahreman et al.   Wang et al.   Archavlis and Carvi y Nievas   Kotani et al.   Parker et al.
  ------------------------------------------------------------ ------------------ ------------- ------------------------------ --------------- ---------------
  \(1\) A clearly stated aim                                   2                  2             2                              2               2
  \(2\) Inclusion of consecutive patients                      1                  2             2                              1               1
  \(3\) Prospective collection of data                         2                  2             2                              2               2
  \(4\) Endpoints appropriate to the aim of the study          2                  2             2                              2               2
  \(5\) Unbiased assessment of the study end point             0                  0             0                              0               0
  \(6\) Follow-up period appropriate to the aim of the study   1                  1             2                              2               2
  \(7\) Loss to follow-up less than 5%                         2                  2             2                              2               2
  \(8\) Prospective calculation of the study size              0                  0             0                              0               0
  \(9\) An adequate control group                              2                  2             2                              2               2
  \(10\) Contemporary groups                                   2                  2             2                              2               2
  \(11\) Baseline equivalence of groups                        2                  2             2                              2               2
  \(12\) Adequate statistical analyses                         2                  2             2                              2               2
  Total scores                                                 18                 19            20                             19              19

###### 

The summary of outcomes of included studies.

  -----------------------------------------------------------------------------------------------------------------------------------
  Authors                 Ghahreman et al.     Wang et al.       Archavlis and Carvi y Nievas   Kotani et al.      Parker et al.
  ----------------------- -------------------- ----------------- ------------------------------ ------------------ ------------------
  Operative time (mins)   MI: 236 ± 68\        MI: 156 ± 32\     MI: 220 ± 48\                  MI: 172 ± 33\      MI: 284 ± 95\
                          OP: 213 ± 67         OP: 145 ± 27      OP: 190 ± 65                   OP: 176 ± 37       OP: 230 ± 67

  EBL                     ---                  MI: 264 ± 89\     MI: 185 ± 140\                 MI: 184 ± 36\      MI: 233 ± 229\
                                               OP: 673 ± 145     OP: 255 ± 468                  OP: 453 ± 243      OP: 383 ± 305

  Hospital stay           MI: 4 ± 1.58\        MI: 10.6 ± 2.5\   ---                            ---                MI: 3 ± 1.53\
                          OP: 6.67 ± 2.36      OP: 14.6 ± 3.8                                                      OP: 4 ± 1.53

  Back pain VAS           MI: 2.67 ± 3.14\     MI: 0.92 ± 0.5\   ---                            ---                MI: 3.3 ± 2.9\
                          OP: 2 ± 3.13         OP: 1.1 ± 0.6                                                       OP: 3.6 ± 2.8

  Leg pain VAS            MI: 1.33 ± 2.36\     ---               ---                            ---                MI: 3 ± 3\
                          OP: 1.67 ± 3.13                                                                          OP: 2.7 ± 2.6

  ODI                     ---                  MI: 10.8 ± 3.3\   ---                            MI: 12.8 ± 13.3\   MI: 11 ± 9.4\
                                               OP: 12.2 ± 3.9                                   OP: 36.5 ± 12.9    OP: 15.6 ± 10.3

  SF-36 PCS               MI: 64.33 ± 40.98\   ---               ---                            ---                MI: 44.3 ± 11.2\
                          OP: 56.67 ± 35.37                                                                        OP: 41.3 ± 11.8

  SF-36 MCS               MI: 76.67 ± 18.87\   ---               ---                            ---                MI: 54.5 ± 10.8\
                          OP: 72.67 ± 36.16                                                                        OP: 52 ± 10.1

  Complications           MI: 0/25\            MI: 4/42\         MI: 7/24\                      ---                MI: 3/50\
                          OP: 2/27             OP: 3/43          OP: 7/25                                          OP: 4/50

  Nonfusion               MI: 0/25\            MI: 1/42\         MI: 2/24\                      MI: 1/43\          ---
                          OP: 1/27             OP: 1/43          OP: 1/25                       OP: 0/37           

  Secondary Surgery       ---                  MI: 2/42\         MI: 2/24\                      ---                MI: 2/50\
                                               OP: 1/43          OP: 2/25                                          OP: 3/50
  -----------------------------------------------------------------------------------------------------------------------------------

MI: minimally invasive surgery group; OP: open surgery group; EBL: estimated blood loss; VAS: visual analog scale; ODI: Oswestry disability index; SF-36 PCS: Short Form-36 physical component scores; SF-36 MCS: Short Form-36 mental component scores.
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